<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 23:54:12[mciao0827] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<header>
<title>Multiplex ligation-dependent probe amplification</title>
<id>9346573</id>
<revision>
<id>244117116</id>
<timestamp>2008-10-09T12:40:22Z</timestamp>
<contributor>
<username>Guroadrunner</username>
<id>770510</id>
</contributor>
</revision>
<categories>
<category>Molecular biology</category>
<category>Amplifiers</category>
<category>Polymerase chain reaction</category>
</categories>
</header>
<bdy>

<b>Multiplex ligation-dependent probe amplification</b> (<b>MLPA</b>)<weblink xlink:type="simple" xlink:href="http://www.mlpa.com">
http://www.mlpa.com</weblink> is a variation of the <link xlink:type="simple" xlink:href="../647/23647.xml">
polymerase chain reaction</link> that permits multiple targets to be amplified with only a single <link xlink:type="simple" xlink:href="../650/23650.xml">
primer</link> pair<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref>. Each probe consists of a two oligonucleotides which recognise adjacent target sites on the <link xlink:type="simple" xlink:href="../955/7955.xml">
DNA</link>. One probe oligonuclotide contains the <link xlink:type="simple" xlink:href="../607/7075607.xml">
sequence</link> recognised by the forward primer, the other the sequence recognised by the reverse primer. Only when both probe oligonucleotides are hybridised to their respective targets, can they be <link xlink:type="simple" xlink:href="../331/18331.xml">
ligated</link> into a complete probe.  The advantage of splitting the probe into two parts is that only the ligated oligonucleotides, but not the unbound probe oligonucleotides, are amplified. If the probes were not split in this way, the primer sequences at either end would cause the probes to be amplified regardless of their hybridisation to the template DNA, and the amplification product would not be dependent on the number of target sites present in the sample DNA. Each complete probe has a unique length, so that its resulting <link xlink:type="simple" xlink:href="../098/914098.xml">
amplicon</link>s can be separated and identified by (capillary) <chemical_analysis wordnetid="100646833" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../582/12582.xml">
electrophoresis</link></chemical_analysis>
. This avoids the resolution limitations of <technique wordnetid="105665146" confidence="0.8">
<know-how wordnetid="105616786" confidence="0.8">
<method wordnetid="105660268" confidence="0.8">
<link xlink:type="simple" xlink:href="../647/23647.xml#xpointer(//*[./st=%22Practical+modifications+to+the+PCR+technique%22])">
multiplex PCR</link></method>
</know-how>
</technique>
. Since the forward primer used for probe amplification is <link xlink:type="simple" xlink:href="../555/11555.xml">
fluorescent</link>ly labelled, each amplicon generates a fluorescent peak which can detected by a capillary sequencer. Comparing the peak pattern obtained on a given sample with that obtained on various reference samples, the relative quantity of each amplicon can be determined. This ratio is a measure for the ratio in which the target sequence is present in the sample DNA.<p>

<image width="150px" src="MLPA_in_GeneMarker.jpg‎">
<caption>

MLPA_in_GeneMarker.jpg‎
</caption>
</image>
</p>
<p>

Various techniques including DGGE (<link xlink:type="simple" xlink:href="../139/1641139.xml">
Denaturing Gradient Gel Electrophoresis</link>), DHPLC (<link xlink:type="simple" xlink:href="../251/9007251.xml">
Denaturing High Performance Liquid Chromatography</link>), and SSCA (<link>
Single Strand Conformation Analysis</link>) effectively identify SNPs and small insertions and deletions. MLPA, however, is one of the only accurate, time-efficient techniques to detect genomic deletions and insertions (one or more entire exons), which are frequent causes of cancers such as hereditary non-polyposis colorectal cancer (<link xlink:type="simple" xlink:href="../539/1223539.xml">
HNPCC</link>), breast, and ovarian cancer.  MLPA can successfully and easily determine the relative copy number of all exons within a gene simultaneously with high sensitivity.</p>

<sec>
<st>
 Relative ploidy </st>
<p>

An important use of MLPA is to determine relative <link xlink:type="simple" xlink:href="../219/23219.xml">
ploidy</link>. For example, probes may be designed to target various regions of <link xlink:type="simple" xlink:href="../438/6438.xml">
chromosome</link> 21 of a human cell.  The signal strengths of the probes are compared with those obtained from a reference DNA sample known to have two copies of the chromosome. If an extra copy is present in the test sample, the signals are expected to be 1.5 times the intensities of the respective probes from the reference. If only one copy is present the proportion is expected to be 0.5. If the sample has two copies, the relative probe strengths are expected to be equal.</p>

</sec>
<sec>
<st>
 Dosage quotient analysis </st>
<p>

Dosage quotient analysis is the usual method of interpreting MLPA data<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref>. If a and b are the signals from two amplicons in the patient sample, and A and B are the corresponding amplicons in the experimental control, then the dosage quotient DQ = (a/b) / (A/B). Although dosage quotients may be calculated for any pair of amplicons, it is usually the case that one of the pair is an internal reference probe. </p>

</sec>
<sec>
<st>
 Applications of MLPA </st>
<p>

MLPA has a variety of applications<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref> including detection of <link xlink:type="simple" xlink:href="../702/19702.xml">
mutation</link>s and <link xlink:type="simple" xlink:href="../091/513091.xml">
single nucleotide polymorphism</link>s<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref>, analysis of DNA <link xlink:type="simple" xlink:href="../188/89188.xml">
methylation</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref>, relative <link xlink:type="simple" xlink:href="../232/20232.xml">
mRNA</link> quantification<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref>, chromosomal characterisation of cell lines and tissue samples<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref>, detection of duplications and deletions in human <link xlink:type="simple" xlink:href="../219/105219.xml">
cancer</link> predisposition genes such as BRCA1,  BRCA2, <link>
hMLH1</link> and <link>
hMSH2</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref> and <link xlink:type="simple" xlink:href="../793/308793.xml">
aneuploidy</link> determination<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref>. MLPA has potential application in <link xlink:type="simple" xlink:href="../286/647286.xml">
prenatal diagnosis</link> both <link xlink:type="simple" xlink:href="../808/1179808.xml">
invasive</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref> and <link xlink:type="simple" xlink:href="../188/1172188.xml">
noninvasive</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref>.</p>

</sec>
<sec>
<st>
 References </st>

<p>

<reflist>
<entry id="1">
 <cite style="font-style:normal">Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G&#32;(2002).&#32;"Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification". <it>Nucleic Acids Res.</it>&#32;<b>30</b>: e57. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1093%2Fnar%2Fgnf056">
10.1093/nar/gnf056</weblink>. PMID 12060695.</cite>&nbsp;</entry>
<entry id="2">
 <cite style="font-style:normal">Yau SC, Bobrow M, Mathew CG, Abbs SJ&#32;(1996).&#32;"Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis". <it>J. Med. Genet.</it>&#32;<b>33</b>: 550&ndash;558. PMID 8818939.</cite>&nbsp;</entry>
<entry id="3">
<weblink xlink:type="simple" xlink:href="http://www.mrc-holland.com/pages/article_pagepag.html">
List of MLPA related articles</weblink></entry>
<entry id="4">
 <cite style="font-style:normal">Volikos E, Robinson J, Aittomaki K, Mecklin JP, Jarvinen H, Westerman AM, de Rooji FW, Vogel T, Moeslein G, Launonen V, Tomlinson IP, Silver AR, Aaltonen LA&#32;(2006).&#32;"LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome". <it>J. Med. Genet.</it>&#32;<b>43</b>: e18. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1136%2Fjmg.2005.039875">
10.1136/jmg.2005.039875</weblink>. PMID 16648371.</cite>&nbsp;</entry>
<entry id="5">
 <cite style="font-style:normal">Procter M, Chou LS, Tang W, Jama M, Mao R&#32;(2006).&#32;"Molecular diagnosis of Prader-Willi and Angelman syndromes by methylation-specific melting analysis and methylation-specific multiplex ligation-dependent probe amplification". <it>Clin. Chem.</it>&#32;<b>52</b>: 1276&ndash;1283. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1373%2Fclinchem.2006.067603">
10.1373/clinchem.2006.067603</weblink>. PMID 16690734.</cite>&nbsp;</entry>
<entry id="6">
 <cite style="font-style:normal">Wehner M, Mangold E, Sengteller M, Friedrichs N, Aretz S, Friedl W, Propping P, Pagenstecher C&#32;(2005).&#32;"Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes". <it>Eur. J. Hum. Genet.</it>&#32;<b>13</b>: 983&ndash;986. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1038%2Fsj.ejhg.5201421">
10.1038/sj.ejhg.5201421</weblink>. PMID 15870828.</cite>&nbsp;</entry>
<entry id="7">
 <cite style="font-style:normal">Wilting SM, Snijders PJ, Meijer GA, Ylstra B, van den Ijssel PR, Snijders AM,Albertson DG, Coffa J, Schouten JP, van de Wiel MA, Meijer CJ, Steenbergen RD&#32;(2006).&#32;"Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix". <it>J. Pathol.</it>&#32;<b>209</b>: 220&ndash;230. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fpath.1966">
10.1002/path.1966</weblink>. PMID 16538612.</cite>&nbsp;</entry>
<entry id="8">
 <cite style="font-style:normal">Bunyan DJ, Eccles DM, Sillibourne J, Wilkins E, Thomas NS, Shea-Simonds J, Duncan PJ, Curtis CE, Robinson DO, Harvey JF, Cross NC&#32;(2004).&#32;"Dosage analysis of cancer predisposition genes by Multiplex Ligation-Dependent Probe Amplification". <it>Br. J. Cancer</it>&#32;<b>91</b>: 1155&ndash;1159. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1038%2Fsj.bjc.6602121">
10.1038/sj.bjc.6602121</weblink>. PMID 15475941.</cite>&nbsp;</entry>
<entry id="9">
 <cite style="font-style:normal">Gerdes T, Kirchhoff M, Lind AM, Larsen GV, Schwartz M, Lundsteen C&#32;(2005).&#32;"Computer-assisted prenatal aneuploidy screening for chromosome 13, 18, 21, X and Y based on multiplex ligation-dependent probe amplification (MLPA)". <it>Eur. J. Hum. Genet.</it>&#32;<b>13</b>: 171&ndash;175. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1038%2Fsj.ejhg.5201307">
10.1038/sj.ejhg.5201307</weblink>. PMID 15483643.</cite>&nbsp;</entry>
<entry id="10">
 <cite style="font-style:normal">Hochstenbach R, Meijer J, van de Brug J, Vossebeld-Hoff I, Jansen R, van der Luijt RB, Sinke RJ, Page-Christiaens GC, Ploos van Amstel JK, de Pater JM&#32;(2005).&#32;"Rapid detection of chromosomal aneuploidies in uncultured amniocytes by multiplex ligation-dependent probe amplification (MLPA)". <it>Prenat. Diagn.</it>&#32;<b>25</b>: 1032–1039. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fpd.1247">
10.1002/pd.1247</weblink>. PMID 16231311.</cite>&nbsp;</entry>
<entry id="11">
 <cite style="font-style:normal">Illanes S, Avent N, Soothill PW&#32;(2005).&#32;"Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound". <it>Ultrasound Obstet. Gynecol.</it>&#32;<b>25</b>: 317&ndash;322. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2Fuog.1881">
10.1002/uog.1881</weblink>. PMID 15789415.</cite>&nbsp;</entry>
</reflist>
</p>

</sec>
<sec>
<st>
External links</st>
<p>

<list>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.softgenetics.com/">
SoftGenetics</weblink> <b><it>GeneMarker</it></b> fragment analysis software</entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.mlpa.com">
MLPA Resources</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.leedsdna.info/science/dosage/Conventional_MLPA/Conventional_MLPA.htm">
Conventional MLPA analysis</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.premierbiosoft.com/bacterial-identification/realtime-PCR/mlpa.html">
 MLPA probe design software</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.leedsdna.info/science/dosage/REX-MLPA/REX-MLPA.htm">
Regression-enhanced MLPA analysis</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.ColonCancerFamily.com/">
ColonCancerFamily.com FREE Newsletter: topics include Lynch Syndrome, HNPCC, Genetic Testing and more</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.ngrl.org.uk/Manchester/Informaticspubs.htm">
Dosage analysis examples</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.ngrl.co.uk/Wessex/mlpa.htm">
Further applications of MLPA</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.safenoe.org">
Special non-invasive advances in fetal and neonatal evaluation network (SAFE)</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.safenoe.org/questions/faq">
SAFE Network non-invasive prenatal diagnosis FAQs page</weblink></entry>
</list>
</p>


</sec>
</bdy>
</article>
